ODTX
Income statement / Annual
Last year (2025), Odyssey Therapeutics Inc's total revenue was $2.98 M,
and the percentage change from the previous year is not available.
In 2025, Odyssey Therapeutics Inc's net income was -$148.65 M.
See Odyssey Therapeutics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
| Period Ended |
12/31/2025 |
| Operating Revenue |
$2.98 M |
| Cost of Revenue |
$0.00
|
| Gross Profit |
$2.98 M
|
| Gross Profit Ratio |
1
|
| Research and Development Expenses |
$126.62 M
|
| General & Administrative Expenses |
$37.52 M
|
| Selling & Marketing Expenses |
$0.00
|
| Selling, General & Administrative Expenses |
$37.52 M
|
| Other Expenses |
$0.00
|
| Operating Expenses |
$164.13 M
|
| Cost And Expenses |
$164.13 M
|
| Interest Income |
$6.35 M
|
| Interest Expense |
$17.00 K
|
| Depreciation & Amortization |
$4.91 M
|
| EBITDA |
-$144.65 M |
| EBITDA Ratio |
-48.6
|
| Operating Income Ratio |
-54.15
|
| Total Other Income/Expenses Net |
$11.58 M
|
| Income Before Tax |
-$149.57 M
|
| Income Before Tax Ratio |
-50.26
|
| Income Tax Expense |
-$927.00 K
|
| Net Income |
-$148.65 M
|
| Net Income Ratio |
-49.95
|
| EPS |
-5.39 |
| EPS Diluted |
-5.39 |
| Weighted Average Shares Out |
$27.56 M
|
| Weighted Average Shares Out Diluted |
$27.56 M
|
| Link |
|
